Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Oosterom

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Intellectual Disability Research : JIDR|September 20, 2021
The LEDs move pilot study: the Light Curtain and physical activity and well-being among people with visual and intellectual disabilitiesL Enkelaar, R Oosterom-Calo, D Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1984
Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in manS W Lamberts, T Verleun, R Oosterom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophyJ Marrink, R Oosterom, H M Bonfrer, et al.
Journal of Endocrinological Investigation|April 1, 1987
Human medullary thyroid carcinoma in tissue culture; secretion of calcitonin and carcinoembryonic antigenR Oosterom, T Verleun, H A Bruining, et al.
Lancet (London, England)|July 25, 1992
Bioavailability of interleukin-2 after reconstitution with albuminC H Lamers, G Stoter, S H Goey, et al.
Acta Endocrinologica|September 1, 1986
Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressinR Oosterom, T Verleun, H A Bruining, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Neuron-specific enolase as a guide to the treatment of small cell lung cancerT A Splinter, E H Cooper, G S Kho, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1982
Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonistS W Lamberts, J M Timmers, R Oosterom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholineL C Pronk, A S Planting, R Oosterom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancerC J Rodenburg, K Nooter, H Herweijer, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Intellectual Disability Research : JIDR|September 20, 2021
The LEDs move pilot study: the Light Curtain and physical activity and well-being among people with visual and intellectual disabilitiesL Enkelaar, R Oosterom-Calo, D Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1984
Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in manS W Lamberts, T Verleun, R Oosterom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophyJ Marrink, R Oosterom, H M Bonfrer, et al.
Journal of Endocrinological Investigation|April 1, 1987
Human medullary thyroid carcinoma in tissue culture; secretion of calcitonin and carcinoembryonic antigenR Oosterom, T Verleun, H A Bruining, et al.
Lancet (London, England)|July 25, 1992
Bioavailability of interleukin-2 after reconstitution with albuminC H Lamers, G Stoter, S H Goey, et al.
Acta Endocrinologica|September 1, 1986
Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressinR Oosterom, T Verleun, H A Bruining, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Neuron-specific enolase as a guide to the treatment of small cell lung cancerT A Splinter, E H Cooper, G S Kho, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1982
Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonistS W Lamberts, J M Timmers, R Oosterom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholineL C Pronk, A S Planting, R Oosterom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancerC J Rodenburg, K Nooter, H Herweijer, et al.
Pageof 7